Day One Biopharmaceuticals
DAWN
DAWN
149 hedge funds and large institutions have $1.2B invested in Day One Biopharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 44 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $1.12B → $1.2B (+$80.1M)
1% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $1.29M
5.03% less ownership
Funds ownership: 88.36% → 83.33% (-5%)
Holders
149
Holding in Top 10
6
Calls
$1.31M
Puts
$1.29M
Top Buyers
| 1 | +$20.8M | |
| 2 | +$12M | |
| 3 | +$7.21M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$5.56M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.89M |
Top Sellers
| 1 | -$33.7M | |
| 2 | -$19.5M | |
| 3 | -$15.7M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$14.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.02M |